1 786 170 EFFECT OF YOGA BREATHING (PRANAYAMA) ON EXERCISE TOLERANCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A RANDOMIZED, CONTROLLED TRIAL. OBJECTIVE: PULMONARY REHABILITATION IMPROVES EXERCISE TOLERANCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). HOWEVER, MANY PATIENTS DO NOT HAVE ACCESS TO PULMONARY REHABILITATION PROGRAMS. WE HYPOTHESIZED THAT AN ALTERNATIVE TO PULMONARY REHABILITATION TO IMPROVE EXERCISE TOLERANCE IS THE PRACTICE OF PRANAYAMA, OR YOGA BREATHING, WHICH COULD BE DONE INDEPENDENTLY AT HOME. WE ALSO SOUGHT TO DETERMINE WHETHER YOGA NONPROFESSIONALS COULD ADEQUATELY TEACH PRANAYAMA TO PATIENTS. DESIGN: PROOF-OF-CONCEPT, RANDOMIZED, DOUBLE-BLIND, CONTROLLED PILOT TRIAL. SETTINGS/LOCATION: TWO ACADEMIC PULMONARY PRACTICES. SUBJECTS: FORTY-THREE PATIENTS WITH SYMPTOMATIC, MODERATE-TO-SEVERE COPD. INTERVENTIONS: TWELVE WEEKS OF PRANAYAMA PLUS EDUCATION VERSUS EDUCATION ALONE. TWO YOGA PROFESSIONALS TRAINED THE RESEARCH COORDINATORS TO CONDUCT ALL PRANAYAMA TEACHING AND MONITORED THE QUALITY OF THE TEACHING AND THE PRACTICE OF PRANAYAMA BY STUDY PARTICIPANTS. OUTCOME MEASURES: THE PRIMARY OUTCOME WAS A CHANGE IN THE 6-MIN WALK DISTANCE (6MWD). SECONDARY OUTCOMES INCLUDED CHANGES IN LUNG FUNCTION, MARKERS OF OXIDATIVE STRESS AND SYSTEMIC INFLAMMATION, AND MEASURES OF DYSPNEA AND QUALITY OF LIFE. RESULTS: THE 6MWD INCREASED IN THE PRANAYAMA GROUP (LEAST SQUARE MEAN [95% CONFIDENCE INTERVAL] = 28 M [-5 TO 61]) AND DECREASED IN THE CONTROL GROUP (-15 M [-47 TO 16]), WITH A NEARLY SIGNIFICANT TREATMENT EFFECT (P = 0.06) IN FAVOR OF PRANAYAMA. PRANAYAMA ALSO RESULTED IN SMALL IMPROVEMENTS IN INSPIRATORY CAPACITY AND AIR TRAPPING. BOTH GROUPS HAD SIGNIFICANT IMPROVEMENTS IN VARIOUS MEASURES OF SYMPTOMS, BUT NO OVERALL DIFFERENCES IN RESPIRATORY SYSTEM IMPEDANCE OR MARKERS OF OXIDATIVE STRESS OR SYSTEMIC INFLAMMATION. CONCLUSION: THIS PILOT STUDY SUCCESSFULLY DEMONSTRATED THAT PRANAYAMA WAS ASSOCIATED WITH IMPROVED EXERCISE TOLERANCE IN PATIENTS WITH COPD. LAY PERSONNEL WERE ABLE TO ADEQUATELY TEACH PATIENTS TO PRACTICE PRANAYAMA. THESE RESULTS SUGGEST THAT PRANAYAMA MAY HAVE SIGNIFICANT CLINICAL BENEFITS FOR SYMPTOMATIC PATIENTS WITH COPD, A CONCEPT THAT NEEDS TO BE CONFIRMED IN FUTURE, LARGER CLINICAL TRIALS. 2017 2 2699 54 YOGA INTERVENTION FOR ADULTS WITH MILD-TO-MODERATE ASTHMA: A PILOT STUDY. BACKGROUND: PRELIMINARY STUDIES INVESTIGATING YOGA AND BREATH WORK FOR TREATING ASTHMA HAVE BEEN PROMISING. SEVERAL RANDOMIZED CONTROLLED TRIALS HAVE SHOWN A BENEFIT FROM YOGA POSTURES AND BREATHING VS CONTROL, BUT THE CONTROL IN THESE CASES INVOLVED NO INTERVENTION OTHER THAN USUAL CARE. THIS STUDY ADVANCES THE FIELD BY PROVIDING AN ACTIVE CONTROL. OBJECTIVE: TO DETERMINE THE EFFECTIVENESS AND FEASIBILITY OF A YOGA AND BREATH WORK INTERVENTION FOR IMPROVING CLINICAL INDICES AND QUALITY OF LIFE IN ADULTS WITH MILD-TO-MODERATE ASTHMA. METHODS: A RANDOMIZED, CONTROLLED, DOUBLE-MASKED CLINICAL TRIAL WAS CONDUCTED BETWEEN OCTOBER 1, 2001, AND MARCH 31, 2003. RANDOM ASSIGNMENT WAS MADE TO EITHER A 4-WEEK YOGA INTERVENTION THAT INCLUDED POSTURES AND BREATH WORK OR A STRETCHING CONTROL CONDITION. OUTCOME MEASURES WERE EVALUATED AT 4, 8, 12, AND 16 WEEKS AND INCLUDED THE MINI ASTHMA QUALITY OF LIFE QUESTIONNAIRE, RESCUE INHALER USE, SPIROMETRY, SYMPTOM DIARIES, AND HEALTH CARE UTILIZATION. RESULTS: SIXTY-TWO PARTICIPANTS WERE RANDOMIZED TO THE INTERVENTION AND CONTROL GROUPS, AND 45 COMPLETED THE FINAL FOLLOW-UP MEASURES. INTENTION-TO-TREAT ANALYSIS WAS PERFORMED. SIGNIFICANT WITHIN-GROUP DIFFERENCES IN POSTBRONCHODILATOR FORCED EXPIRATORY VOLUME IN 1 SECOND AND MORNING SYMPTOM SCORES WERE APPARENT IN BOTH GROUPS AT 4 AND 16 WEEKS; HOWEVER, NO SIGNIFICANT DIFFERENCES BETWEEN GROUPS WERE OBSERVED ON ANY OUTCOME MEASURES. CONCLUSIONS: IYENGAR YOGA CONFERRED NO APPRECIABLE BENEFIT IN MILD-TO-MODERATE ASTHMA. CIRCUMSTANCES UNDER WHICH YOGA IS OF BENEFIT IN ASTHMA MANAGEMENT, IF ANY, REMAIN TO BE DETERMINED. 2005 3 2609 63 YOGA FOR QUALITY OF LIFE IN INDIVIDUALS WITH CHRONIC DISEASE: A SYSTEMATIC REVIEW. BACKGROUND: CHRONIC DISEASES, INCLUDING HEART DISEASE, STROKE, CANCER, AND CHRONIC PULMONARY DISEASE ARE THE LEADING CAUSES OF DEATH AND DISABILITY WORLDWIDE. COMPOUNDING SYMPTOMS AND LOSS OF FUNCTION, PEOPLE LIVING WITH CHRONIC DISEASE OFTEN EXPERIENCE REDUCED QUALITY OF LIFE (QOL). VARIOUS PHYSICAL AND MENTAL PRACTICES HAVE BEEN SHOWN TO RELIEVE STRESS AND IMPROVE QOL. YOGA IS A PHYSICAL AND MENTAL PRACTICE THAT MAY BE A VIABLE APPROACH FOR IMPROVING QOL IN PEOPLE WITH CHRONIC DISEASE. OBJECTIVE: THE OBJECTIVE OF THIS STUDY WAS TO EXAMINE AND SUMMARIZE THE EVIDENCE FOR THE EFFECTIVENESS OF YOGA ON QOL IN PATIENTS WITH CHRONIC DISEASE. DESIGN: THE STUDY DESIGN WAS A A SYSTEMATIC REVIEW WITH QUALITATIVE SYNTHESIS. METHODS: WE INCLUDED RANDOMIZED CONTROLLED TRIALS THAT EVALUATED THE EFFECT OF YOGA ON QOL OR HEALTH-RELATED QOL (HRQOL) FOR INDIVIDUALS WITH CHRONIC DISEASE. WE INCLUDED ONLY STUDIES THAT USED AT LEAST 1 PREVIOUSLY VALIDATED MEASURE OF QOL OR HRQOL AND SPECIFIED A MINIMUM DURATION OF FOLLOW-UP OF AT LEAST 1 WK. INTERVENTIONS: WE INCLUDED BOTH MOVEMENT-BASED AND BREATH-BASED YOGA PRACTICES. STUDIES THAT INCLUDED YOGA AS PART OF A LARGER INTERVENTION PROGRAM (EG, MINDFULNESS-BASED STRESS REDUCTION TRAINING) OR STUDIES THAT DID NOT PROVIDE FINDINGS SPECIFIC TO YOGA WERE EXCLUDED. PRIMARY OUTCOME MEASURES: THE PRIMARY OUTCOME ANALYZED WAS IMPROVEMENT IN QOL AS MEASURED BY A VALIDATED QOL OR HRQOL SCALE. RESULTS: AMONG THE 1488 STUDIES THAT WERE IDENTIFIED ON INITIAL SEARCH, 7 ARTICLES MET ALL INCLUSION CRITERIA. FIVE STUDIES REPORTED A STATISTICALLY SIGNIFICANT ADVANTAGE OVER USUAL CARE ALONE FOR IMPROVEMENT OF QOL IN PATIENTS WITH CHRONIC DISEASE, BUT THE CLINICAL SIGNIFICANCE OF THE DIFFERENCES WAS CLEAR IN ONLY 1 TRIAL. WE FOUND CONSIDERABLE HETEROGENEITY AMONG THE INCLUDED STUDIES AND STUDY QUALITY WAS GENERALLY LOW. CONCLUSIONS: MORE HIGH-QUALITY RESEARCH IS NEEDED TO DETERMINE THE VALUE OF YOGA AS AN ADJUNCTIVE APPROACH TO IMPROVING QOL IN PATIENTS WITH CHRONIC DISEASE. 2019 4 2235 37 THE IMPACT OF YOGA UPON FEMALE PATIENTS SUFFERING FROM HYPOTHYROIDISM. OBJECTIVE: TO STUDY THE EFFECT OF YOGA ON THE QUALITY OF LIFE OF FEMALE HYPOTHYROID PATIENTS. DESIGN: THE WHO QUALITY OF LIFE SCALE(22) WAS USED TO ASSESS THE QUALITY OF LIFE OF 20 FEMALE HYPOTHYROID PATIENTS. SUBJECTS ATTENDED ONE HOUR YOGA SESSIONS DAILY FOR A PERIOD OF ONE MONTH. A PRETEST-POST-TEST RESEARCH DESIGN WAS USED FOR DATA ANALYSIS. RESULTS: PATIENTS' QUALITY OF LIFE SCORES FOLLOWING THE YOGA PROGRAM WERE GREATER THAN SCORES OBTAINED PRIOR TO UNDERTAKING YOGA (P < 0.01). PATIENTS ALSO REPORTED SIGNIFICANT IMPROVEMENT IN THEIR PERCEPTION OF THE OVERALL QUALITY OF LIFE AND OF THEIR HEALTH POST YOGA INTERVENTION. CONCLUSIONS: IT CAN BE CONCLUDED THAT YOGA IS VALUABLE IN HELPING THE HYPOTHYROID PATIENTS TO MANAGE THEIR DISEASE-RELATED SYMPTOMS. YOGA MAY BE CONSIDERED AS SUPPORTIVE OR COMPLEMENTARY THERAPY IN CONJUNCTION WITH MEDICAL THERAPY FOR THE TREATMENT OF HYPOTHYROID DISORDER. 2011 5 792 53 EFFECT OF YOGA IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE. YOGA IS ADJUNCTIVELY UTILIZED OUTSIDE THE UNITED STATES IN THE TREATMENT OF A VARIETY OF DISEASES, INCLUDING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BUT THERE ARE NO STUDIES ASSESSING ITS ADJUNCTIVE EFFICACY IN THE UNITED STATES. WE PROSPECTIVELY EVALUATED THE EFFECTS OF YOGA TRAINING ON THE QUALITY OF LIFE (QOL) AND THE PARAMETERS OF LUNG FUNCTION IN PATIENTS WITH COPD. THIRTY-THREE PATIENTS WITH DOCUMENTED COPD, PER GLOBAL INITIATIVE FOR OBSTRUCTIVE LUNG DISEASE CRITERIA, WERE RECRUITED. ALL PATIENTS RECEIVED STANDARD COPD CARE. THE QOL WAS ASSESSED BY THE ST. GEORGE RESPIRATORY QUESTIONNAIRE. STANDARD SPIROMETRY AND MAXIMUM INSPIRATORY (MAXIMAL INSPIRATORY PRESSURE) AND EXPIRATORY PRESSURE (MAXIMAL EXPIRATORY PRESSURE) WERE MEASURED. PATIENTS WERE TAUGHT SELECTED YOGA EXERCISES INCLUDING BREATHING EXERCISES, MEDITATION, AND YOGA POSTURES FOR 1 HOUR, THRICE A WEEK FOR 6 WEEKS BY A CERTIFIED YOGA THERAPIST. THE QUALITY OF LIFE AND LUNG FUNCTION WERE AGAIN ASSESSED AT THE END OF 6 WEEKS. TWENTY-TWO PATIENTS COMPLETED THE STUDY. DIFFERENCES IN PREYOGA VERSUS POSTYOGA SCORES WERE EVALUATED USING PAIRED T-TESTS. STATISTICALLY SIGNIFICANT IMPROVEMENTS (P < 0.05) WERE OBSERVED FOR THE ST. GEORGE RESPIRATORY QUESTIONNAIRE [95% CONFIDENCE INTERVAL (CI) 43.13-58.47], VITAL CAPACITY (95% CI 2.53-7.65), MAXIMAL INSPIRATORY PRESSURE (95% CI 6.62-23.64), AND MAXIMAL EXPIRATORY PRESSURE (95% CI 1.63-13.81). YOGA WHEN PRACTICED BY PATIENTS WITH COPD RESULTS IN IMPROVEMENT IN THE QOL AND LUNG FUNCTION ON A SHORT-TERM BASIS. ADDITIONAL RESEARCH IS NEEDED TO CONFIRM THESE FINDINGS IN A RANDOMIZED CONTROLLED TRIAL AND IN THE LONGER TERM. 2012 6 1076 46 EFFECTS OF YOGA ON PHYSIOLOGICAL INDICES, ANXIETY AND SOCIAL FUNCTIONING IN MULTIPLE SCLEROSIS PATIENTS: A RANDOMIZED TRIAL. INTRODUCTION: MULTIPLE SCLEROSIS (MS) AS A CHRONIC DISEASE COULD AFFECT PATIENTS' VARIOUS DOMAINS OF LIFE. AIM: THIS STUDY WAS CONDUCTED TO STUDY THE EFFECT OF YOGA ON THE PHYSIOLOGICAL INDICES, ANXIETY AND SOCIAL FUNCTIONING OF PATIENTS WITH MS IN SOUTHWEST, IRAN. MATERIALS AND METHODS: IN THIS CLINICAL TRIAL STUDY, 60 MS PATIENTS WERE ENROLLED ACCORDING TO INCLUSION CRITERIA AND RANDOMLY ASSIGNED TO TWO GROUPS OF 30 EACH. PRIOR TO AND AFTER INTERVENTION, THE PATIENTS' VITAL SIGNS WERE MEASURED. FOR CASE GROUP YOGA EXERCISES WERE PERFORMED THREE SESSIONS A WEEK FOR 12 WEEKS WHILE CONTROL GROUP PERFORMED NO EXERCISE. THE DATA WERE GATHERED BY QUESTIONNAIRE AND ANALYSED BY DESCRIPTIVE AND ANALYTICAL STATISTICS IN SPSS. RESULTS: PRIOR TO INTERVENTION, THERE WAS NO SIGNIFICANT DIFFERENCE IN FATIGUE SEVERITY AND PAIN BETWEEN THE TWO GROUPS BUT THE MEAN FATIGUE SEVERITY AND PAIN IN CASE GROUP DECREASED COMPARED TO THE CONTROL GROUP AFTER THE INTERVENTION. PRIOR TO INTERVENTION, THERE WAS NO SIGNIFICANT DIFFERENCE IN MEAN PHYSIOLOGICAL INDICES BETWEEN THE TWO GROUPS BUT THE MEAN PHYSIOLOGICAL INDICES IN CASE GROUP DECREASED SIGNIFICANTLY AFTER THE INTERVENTION (P<0.05). CONCLUSION: YOGA IS LIKELY TO INCREASE SELF-EFFICACY OF MS PATIENTS THROUGH ENHANCING PHYSICAL ACTIVITY, INCREASING THE STRENGTH OF LOWER LIMBS AND BALANCE, AND DECREASING FATIGUE AND PAIN, AND FINALLY TO PROMOTE SOCIAL FUNCTIONING AND TO RELIEVE STRESS AND ANXIETY IN THESE PATIENTS. 2016 7 1854 54 RANDOMISED CONTROLLED TRIAL OF A 12 WEEK YOGA INTERVENTION ON NEGATIVE AFFECTIVE STATES, CARDIOVASCULAR AND COGNITIVE FUNCTION IN POST-CARDIAC REHABILITATION PATIENTS. BACKGROUND: NEGATIVE AFFECTIVE STATES SUCH AS ANXIETY, DEPRESSION AND STRESS ARE SIGNIFICANT RISK FACTORS FOR CARDIOVASCULAR DISEASE, PARTICULARLY IN CARDIAC AND POST-CARDIAC REHABILITATION POPULATIONS.YOGA IS A BALANCED PRACTICE OF PHYSICAL EXERCISE, BREATHING CONTROL AND MEDITATION THAT CAN REDUCE PSYCHOSOCIAL SYMPTOMS AS WELL AS IMPROVE CARDIOVASCULAR AND COGNITIVE FUNCTION. IT HAS THE POTENTIAL TO POSITIVELY AFFECT MULTIPLE DISEASE PATHWAYS AND MAY PROVE TO BE A PRACTICAL ADJUNCT TO CARDIAC REHABILITATION IN FURTHER REDUCING CARDIAC RISK FACTORS AS WELL AS IMPROVING SELF-EFFICACY AND POST-CARDIAC REHABILITATION ADHERENCE TO HEALTHY LIFESTYLE BEHAVIOURS. METHOD AND DESIGN: THIS IS A PARALLEL ARM, MULTI-CENTRE, RANDOMISED CONTROLLED TRIAL THAT WILL ASSESS THE OUTCOMES OF POST- PHASE 2 CARDIAC REHABILITATION PATIENTS ASSIGNED TO A YOGA INTERVENTION IN COMPARISON TO A NO-TREATMENT WAIT-LIST CONTROL GROUP. PARTICIPANTS RANDOMISED TO THE YOGA GROUP WILL ENGAGE IN A 12 WEEK YOGA PROGRAM COMPRISING OF TWO GROUP BASED SESSIONS AND ONE SELF-ADMINISTERED HOME SESSION EACH WEEK. GROUP BASED SESSIONS WILL BE LED BY AN EXPERIENCED YOGA INSTRUCTOR. THIS WILL INVOLVE TEACHING BEGINNER STUDENTS A HATHA YOGA SEQUENCE THAT INCORPORATES ASANA (POSES AND POSTURES), PRANAYAMA (BREATHING CONTROL) AND MEDITATION. THE PRIMARY OUTCOMES OF THIS STUDY ARE NEGATIVE AFFECTIVE STATES OF ANXIETY, DEPRESSION AND STRESS ASSESSED USING THE DEPRESSION ANXIETY STRESS SCALE. SECONDARY OUTCOMES INCLUDE MEASURES OF QUALITY OF LIFE, AND CARDIOVASCULAR AND COGNITIVE FUNCTION. THE CARDIOVASCULAR OUTCOMES WILL INCLUDE BLOOD PRESSURE, HEART RATE, HEART RATE VARIABILITY, PULSE WAVE VELOCITY, CAROTID INTIMA MEDIA THICKNESS MEASUREMENTS, LIPID/GLUCOSE PROFILES AND C-REACTIVE PROTEIN ASSAYS. ASSESSMENTS WILL BE CONDUCTED PRIOR TO (WEEK 0), MID-WAY THROUGH (WEEK 6) AND FOLLOWING THE INTERVENTION PERIOD (WEEK 12) AS WELL AS AT A FOUR WEEK FOLLOW-UP (WEEK 16). DISCUSSION: THIS STUDY WILL DETERMINE THE EFFECT OF YOGA PRACTICE ON NEGATIVE AFFECTIVE STATES, CARDIOVASCULAR AND COGNITIVE FUNCTION IN POST-PHASE 2 CARDIAC REHABILITATION PATIENTS. THE FINDINGS MAY PROVIDE EVIDENCE TO INCORPORATE YOGA INTO STANDARDISED CARDIAC REHABILITATION PROGRAMS AS A PRACTICAL ADJUNCT TO IMPROVE THE MANAGEMENT OF PSYCHOSOCIAL SYMPTOMS ASSOCIATED WITH CARDIOVASCULAR EVENTS IN ADDITION TO IMPROVING PATIENTS' COGNITIVE AND CARDIOVASCULAR FUNCTIONS. TRIAL REGISTRATION: ACTRN12612000358842. 2014 8 2508 65 YOGA BREATHING FOR CANCER CHEMOTHERAPY-ASSOCIATED SYMPTOMS AND QUALITY OF LIFE: RESULTS OF A PILOT RANDOMIZED CONTROLLED TRIAL. BACKGROUND: MANY DEBILITATING SYMPTOMS ARISE FROM CANCER AND ITS TREATMENT THAT ARE OFTEN UNRELIEVED BY ESTABLISHED METHODS. PRANAYAMA, A SERIES OF YOGIC BREATHING TECHNIQUES, MAY IMPROVE CANCER-RELATED SYMPTOMS AND QUALITY OF LIFE, BUT IT HAS NOT BEEN STUDIED FOR THIS PURPOSE. OBJECTIVES: A PILOT STUDY WAS PERFORMED TO EVALUATE FEASIBILITY AND TO TEST THE EFFECTS OF PRANAYAMA ON CANCER-ASSOCIATED SYMPTOMS AND QUALITY OF LIFE. DESIGN: THIS WAS A RANDOMIZED CONTROLLED CLINICAL TRIAL COMPARING PRANAYAMA TO USUAL CARE. SETTING: THE STUDY WAS CONDUCTED AT A UNIVERSITY MEDICAL CENTER. SUBJECTS: PATIENTS RECEIVING CANCER CHEMOTHERAPY WERE RANDOMIZED TO RECEIVE PRANAYAMA IMMEDIATELY OR AFTER A WAITING PERIOD (CONTROL GROUP). INTERVENTIONS: THE PRANAYAMA INTERVENTION CONSISTED OF FOUR BREATHING TECHNIQUES TAUGHT IN WEEKLY CLASSES AND PRACTICED AT HOME. THE TREATMENT GROUP RECEIVED PRANAYAMA DURING TWO CONSECUTIVE CYCLES OF CHEMOTHERAPY. THE CONTROL GROUP RECEIVED USUAL CARE DURING THEIR FIRST CYCLE, AND RECEIVED PRANAYAMA DURING THEIR SECOND CYCLE OF CHEMOTHERAPY. OUTCOME MEASURES: FEASIBILITY, CANCER-ASSOCIATED SYMPTOMS (FATIGUE, SLEEP DISTURBANCE, ANXIETY, DEPRESSION, STRESS), AND QUALITY OF LIFE WERE THE OUTCOMES. RESULTS: CLASS ATTENDANCE WAS NEARLY 100% IN BOTH GROUPS. SIXTEEN (16) PARTICIPANTS WERE INCLUDED IN THE FINAL INTENT-TO-TREAT ANALYSES. THE REPEATED-MEASURES ANALYSES DEMONSTRATED THAT ANY INCREASE IN PRANAYAMA DOSE, WITH DOSE MEASURED IN THE NUMBER OF HOURS PRACTICED IN CLASS OR AT HOME, RESULTED IN IMPROVED SYMPTOM AND QUALITY-OF-LIFE SCORES. SEVERAL OF THESE ASSOCIATIONS--SLEEP DISTURBANCE (P=0.04), ANXIETY (P=0.04), AND MENTAL QUALITY OF LIFE (P=0.05)--REACHED OR APPROACHED STATISTICAL SIGNIFICANCE. CONCLUSIONS: YOGA BREATHING WAS A FEASIBLE INTERVENTION AMONG PATIENTS WITH CANCER RECEIVING CHEMOTHERAPY. PRANAYAMA MAY IMPROVE SLEEP DISTURBANCE, ANXIETY, AND MENTAL QUALITY OF LIFE. A DOSE-RESPONSE RELATIONSHIP WAS FOUND BETWEEN PRANAYAMA USE AND IMPROVEMENTS IN CHEMOTHERAPY-ASSOCIATED SYMPTOMS AND QUALITY OF LIFE. THESE FINDINGS NEED TO BE CONFIRMED IN A LARGER STUDY. 2012 9 173 49 A RANDOMIZED CONTROLLED STUDY ON ASSESSMENT OF HEALTH STATUS, DEPRESSION, AND ANXIETY IN COAL MINERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE FOLLOWING YOGA TRAINING. CONTEXT: PSYCHOLOGICAL COMORBIDITIES ARE PREVALENT IN COAL MINERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND CONTRIBUTE TO THE SEVERITY OF THE DISEASE REDUCING THEIR HEALTH STATUS. YOGA HAS BEEN SHOWN TO ALLEVIATE DEPRESSION AND ANXIETY ASSOCIATED WITH OTHER CHRONIC DISEASES BUT IN COPD NOT BEEN FULLY INVESTIGATED. AIM: THIS STUDY AIMED TO EVALUATE THE ROLE OF YOGA ON HEALTH STATUS, DEPRESSION, AND ANXIETY IN COAL MINERS WITH COPD. MATERIALS AND METHODS: THIS WAS A RANDOMIZED TRIAL WITH TWO STUDY ARMS (YOGA AND CONTROL), WHICH ENROLLED 81 COAL MINERS, RANGING FROM 36 TO 60 YEARS WITH STAGE II AND III STABLE COPD. BOTH GROUPS WERE EITHER ON CONVENTIONAL TREATMENT OR COMBINATION OF CONVENTIONAL CARE WITH YOGA PROGRAM FOR 12 WEEKS. RESULTS: DATA WERE COLLECTED THROUGH STANDARDIZED QUESTIONNAIRES; COPD ASSESSMENT TEST, BECK DEPRESSION INVENTORY AND STATE AND TRAIT ANXIETY INVENTORY AT THE BEGINNING AND THE END OF THE INTERVENTION. THE YOGA GROUP SHOWED STATISTICALLY SIGNIFICANT (P < 0.001) IMPROVEMENTS ON ALL SCALES WITHIN THE GROUP, ALL SIGNIFICANTLY DIFFERENT (P < 0.001) FROM CHANGES OBSERVED IN THE CONTROLS. NO SIGNIFICANT PREPOST CHANGES WERE OBSERVED IN THE CONTROL GROUP (P > 0.05). CONCLUSION: YOGA PROGRAM LED TO GREATER IMPROVEMENT IN PHYSICAL AND MENTAL HEALTH STATUS THAN DID CONVENTIONAL CARE. YOGA SEEMS TO BE A SAFE, FEASIBLE, AND EFFECTIVE TREATMENT FOR PATIENTS WITH COPD. THERE IS A NEED TO CONDUCT MORE COMPREHENSIVE, HIGH-QUALITY, EVIDENCE-BASED STUDIES TO SHED LIGHT ON THE CURRENT UNDERSTANDING OF THE EFFICACY OF YOGA IN THESE CHRONIC CONDITIONS AND IDENTIFY UNANSWERED QUESTIONS. 2016 10 2222 55 THE IMPACT OF MODIFIED HATHA YOGA ON CHRONIC LOW BACK PAIN: A PILOT STUDY. PURPOSE: THE PURPOSE OF THIS RANDOMIZED PILOT STUDY WAS TO EVALUATE A POSSIBLE DESIGN FOR A 6-WEEK MODIFIED HATHA YOGA PROTOCOL TO STUDY THE EFFECTS ON PARTICIPANTS WITH CHRONIC LOW BACK PAIN. PARTICIPANTS: TWENTY-TWO PARTICIPANTS (M = 4; F = 17), BETWEEN THE AGES OF 30 AND 65, WITH CHRONIC LOW BACK PAIN (CLBP) WERE RANDOMIZED TO EITHER AN IMMEDIATE YOGA BASED INTERVENTION, OR TO A CONTROL GROUP WITH NO TREATMENT DURING THE OBSERVATION PERIOD BUT RECEIVED LATER YOGA TRAINING. METHODS: A SPECIFIC CLBP YOGA PROTOCOL DESIGNED AND MODIFIED FOR THIS POPULATION BY A CERTIFIED YOGA INSTRUCTOR WAS ADMINISTERED FOR ONE HOUR, TWICE A WEEK FOR 6 WEEKS. PRIMARY FUNCTIONAL OUTCOME MEASURES INCLUDED THE FORWARD REACH (FR) AND SIT AND REACH (SR) TESTS. ALL PARTICIPANTS COMPLETED OSWESTRY DISABILITY INDEX (ODI) AND BECK DEPRESSION INVENTORY (BDI) QUESTIONNAIRES. GUIDING QUESTIONS WERE USED FOR QUALITATIVE DATA ANALYSIS TO ASCERTAIN HOW YOGA PARTICIPANTS PERCEIVED THE INSTRUCTOR, GROUP DYNAMICS, AND THE IMPACT OF YOGA ON THEIR LIFE. ANALYSIS: TO ACCOUNT FOR DROP OUTS, THE DATA WERE DIVIDED INTO BETTER OR NOT CATEGORIES, AND ANALYZED USING CHI-SQUARE TO EXAMINE DIFFERENCES BETWEEN THE GROUPS. QUALITATIVE DATA WERE ANALYZED THROUGH FREQUENCY OF POSITIVE RESPONSES. RESULTS: POTENTIALLY IMPORTANT TRENDS IN THE FUNCTIONAL MEASUREMENT SCORES SHOWED IMPROVED BALANCE AND FLEXIBILITY AND DECREASED DISABILITY AND DEPRESSION FOR THE YOGA GROUP BUT THIS PILOT WAS NOT POWERED TO REACH STATISTICAL SIGNIFICANCE. SIGNIFICANT LIMITATIONS INCLUDED A HIGH DROPOUT RATE IN THE CONTROL GROUP AND LARGE BASELINE DIFFERENCES IN THE SECONDARY MEASURES. IN ADDITION, ANALYSIS OF THE QUALITATIVE DATA REVEALED THE FOLLOWING FREQUENCY OF RESPONSES (1) GROUP INTERVENTION MOTIVATED THE PARTICIPANTS AND (2) YOGA FOSTERED RELAXATION AND NEW AWARENESS/LEARNING. CONCLUSION: A MODIFIED YOGA-BASED INTERVENTION MAY BENEFIT INDIVIDUALS WITH CLB, BUT A LARGER STUDY IS NECESSARY TO PROVIDE DEFINITIVE EVIDENCE. ALSO, THE IMPACT ON DEPRESSION AND DISABILITY COULD BE CONSIDERED AS IMPORTANT OUTCOMES FOR FURTHER STUDY. ADDITIONAL FUNCTIONAL OUTCOME MEASURES SHOULD BE EXPLORED. THIS PILOT STUDY SUPPORTS THE NEED FOR MORE RESEARCH INVESTIGATING THE EFFECT OF YOGA FOR THIS POPULATION. 2004 11 1402 51 IMPACT OF YOGA ON BLOOD PRESSURE AND QUALITY OF LIFE IN PATIENTS WITH HYPERTENSION - A CONTROLLED TRIAL IN PRIMARY CARE, MATCHED FOR SYSTOLIC BLOOD PRESSURE. BACKGROUND: MEDICAL TREATMENT OF HYPERTENSION IS NOT ALWAYS SUFFICIENT TO ACHIEVE BLOOD PRESSURE CONTROL. DESPITE THIS, PREVIOUS STUDIES ON SUPPLEMENTARY THERAPIES, SUCH AS YOGA, ARE RELATIVELY FEW. WE INVESTIGATED THE EFFECTS OF TWO YOGA INTERVENTIONS ON BLOOD PRESSURE AND QUALITY OF LIFE IN PATIENTS IN PRIMARY HEALTH CARE DIAGNOSED WITH HYPERTENSION. METHODS: ADULT PATIENTS (AGE 20-80 YEARS) WITH DIAGNOSED HYPERTENSION WERE IDENTIFIED BY AN ELECTRONIC CHART SEARCH AT A PRIMARY HEALTH CARE CENTER IN SOUTHERN SWEDEN. IN TOTAL, 83 SUBJECTS WITH BLOOD PRESSURE VALUES OF 120-179/